Meier E, Jørgensen O S, Schousboe A
Department of Biochemistry A, Panum Institute, Copenhagen, Denmark.
J Neurochem. 1987 Nov;49(5):1462-70. doi: 10.1111/j.1471-4159.1987.tb01015.x.
The effect of treatment with the gamma-aminobutyric acid (GABA) agonist tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) on neural development was monitored in rats by following the expression of the neuron-specific proteins neural cell adhesion molecule (NCAM), D1, and D3 as well as the enzymes glutamate decarboxylase (GAD) and glutamate dehydrogenase (GLDH). As judged from the effect of the treatment on the expression of NCAM and GAD, GABA agonists have the capacity to accelerate and enhance neuronal development during the early postnatal period. However, as judged from the expression of D1- and D3-protein some adverse late effects may result from prolonged treatment with high doses of GABA agonists. The decrease in GLDH specific activity observed in THIP-treated rats during their late postnatal development possibly indicates a repression of glutamatergic neurons.
通过追踪神经元特异性蛋白神经细胞黏附分子(NCAM)、D1和D3以及谷氨酸脱羧酶(GAD)和谷氨酸脱氢酶(GLDH)的表达,监测γ-氨基丁酸(GABA)激动剂四氢异恶唑并[5,4-c]吡啶-3-醇(THIP)对大鼠神经发育的影响。从该治疗对NCAM和GAD表达的影响判断,GABA激动剂有能力在出生后早期加速和增强神经元发育。然而,从D1和D3蛋白的表达判断,高剂量GABA激动剂的长期治疗可能会导致一些不良的后期影响。在THIP处理的大鼠出生后晚期发育过程中观察到的GLDH比活性降低可能表明谷氨酸能神经元受到抑制。